Bio Rad Laboratories Inc
Veridion Score
Composite trend over time
Why is BIO.B moving today?
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for BIO.B.
BIO.B insider activity
Bio Rad Laboratories Inc
No multi-insider buying cluster in the last 90 days
Mixed: $0 across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for BIO.B.
BIO.B contract awards, year to date.
Public federal awards linked to this ticker.
BIO.B lobbying filings, year to date.
Registered lobbying filings matched to Bio Rad Laboratories Inc.
FORBES-TATE
FORBES-TATE